Eagle Pharmaceuticals Inc (NASDAQ:EGRX) announced that Enalare Therapeutics Inc secured a contract for up to $50.3 million from the Biomedical Advanced Research and…
Eagle Pharmaceuticals Inc (NASDAQ:EGRX) has agreed to make a $25 million equity investment in Enalare Therapeutics Inc. The investment consists of upfront…